Skip to main
SNYR

SNYR Stock Forecast & Price Target

SNYR Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Synergy CHC is expected to continue growing its flagship brain health supplement, FOCUSfactor, with over 34 SKUs and expanded distribution to major retailers. The global market for brain health supplements presents substantial opportunities for the company to gain market share. Despite weaker Q4 results, Synergy has a strong financial track record and several upcoming catalysts that could improve visibility and drive the stock price higher, making it undervalued.

Bears say

Synergy CHC is facing several headwinds including cash constraints and debt, weaker Q1 results due to out-of-stock products, and a highly competitive industry. However, the company has shown growth potential through its expanding product line, particularly in the large brain health supplements and energy RTD markets, and has consistently reported profits in recent quarters. With expected progress in sales, profitability, and international expansion, the stock is undervalued despite the current challenges and presents high rewards for the risks.

SNYR has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Synergy CHC Corp (SNYR) Forecast

Analysts have given SNYR a Strong Buy based on their latest research and market trends.

According to 2 analysts, SNYR has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Synergy CHC Corp (SNYR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.